Keywords
Abstract
O‘tkir leykozlar — suyak iligi va qon hosil qiluvchi tizimning xavfli neoplastik kasalliklari bo‘lib, blast hujayralarning nazoratsiz ko‘payishi va differensiyalanish jarayonining buzilishi bilan tavsiflanadi. Ushbu maqolada o‘tkir leykozlarning epidemiologiyasi, klinik belgilar va zamonaviy tashxislash usullari, davolash yondashuvlari hamda profilaktik choralar yoritilgan. Hozirgi kunda immunofenotiplash, sitogenetik va molekulyar-genetik tahlillar tashxis qo‘yishda muhim ahamiyat kasb etmoqda. Davolashda esa kimyoterapiya, maqsadli terapiya, immunoterapiya va suyak iligi transplantatsiyasi asosiy usullar sifatida qo‘llaniladi. Profilaktik choralar esa xavf omillarini kamaytirishga va erta tashxislashga qaratilgan.
References
World Health Organization. Global Cancer Report 2024. Geneva: WHO Press, 2024.
2. National Cancer Institute. Acute Leukemia Statistics and Treatment. NCI, USA, 2023.
3. Hoffbrand A. V., Higgs D. R., Keeling D. M., Mehta A. B. Postgraduate Haematology. 7th edition. Wiley-Blackwell, 2022.
4. Российское общество гематологов. Руководство по диагностике и лечению острых лейкозов. Москва, 2023.
5. Giebel S., et al. “Acute leukemia: advances in molecular diagnostics and targeted therapy.” Blood Reviews, 2022.
6. O‘zbekiston Respublikasi Sog‘liqni Saqlash Vazirligi. Gematologiya bo‘yicha milliy qo‘llanma. Toshkent, 2023.
7. Tallman M.S., Wang E.S., Stone R.M., et al. Acute Myeloid Leukemia, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022.
8. Pui C.H., Yang J.J., Hunger S.P., et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2015.
9. Döhner H., Weisdorf D.J., Bloomfield C.D. Acute Myeloid Leukemia. N Engl J Med. 2015;373:1136-1152.
10. Arber D.A., Orazi A., Hasserjian R., et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
11. Grimwade D., Hills R.K., Moorman A.V., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities. Blood. 2010;116:354-365.
12. Estey E., Döhner H. Acute myeloid leukaemia. Lancet. 2006;368:1894-1907.